Aimovig Components
Aimovig contains erinumab, a human immunoglobulin G2, or monoclonal antibody produced using recombinant DNA technology, and has a high affinity to CGRP receptors.
Aimovig injection uses
Aimovig injection is used to prevent migraines.
Aimovig dosage
-
The appropriate is determined by the doctor.
-
The recommended dose is 70 mg once every 4 weeks.
-
Aimovig is used by subcutaneous injections.
-
The need for treatment should be reassessed in regular periods of 3-6 months.
-
The effectiveness and safety of the drug for those suffering from migraines less than 4 times a month has not been assessed.
Aimovig Side Effects
Aimovig may cause some side effects, such as:
-
Constipation.
-
Nausea and vomiting.
-
Fatigue.
-
erythema and pain in the injection site.
-
respiratory infection.
-
dizziness.
-
Insomnia.
-
Muscle spasm.
-
Pruritus.
Aimovig contraindications
Aimovig is not used in case of allergies to its ingredients.
Â
Aimovig use precautions
The doctor should be consulted before using Aimovig, especially in the following cases:
-
Constipation.
-
High blood pressure.
-
Pregnancy and lactation
